CD4 and breast carcinoma: This study aimed to investigate the prognostic effects of peripheral blood but not tissue infiltrating CD4+CD25+ T cells for BC patients receiving DC-CIK infusions, to testify the feasibility and values of T cell subsets proportion as substitute biomarkers for breast cancer patients.